From Big Data to the clinic: methodological and statistical enhancements to implement the UK Biobank imaging framework in a memory clinic
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction
The analysis tools and statistical methods used in large neuroimaging research studies differ from those applied in clinical contexts, making it unclear whether these techniques can be translated to a memory clinic setting. The Oxford Brain Health Clinic (OBHC) was established in 2020 to bridge this gap between research studies and memory clinics.
Methods
We optimised the UK Biobank imaging framework for the memory clinic setting by integrating enhanced quality control (QC) processes (MRIQC, QUAD, and DSE decomposition) and supplementary dementia-informed analyses (lobar volumes, NBM volumes, WMH classification, PSMD, cortical diffusion MRI metrics, and tract volumes) into the analysis pipeline. We explored associations between resultant imaging-derived phenotypes (IDPs) and clinical phenotypes in the OBHC patient population (N=213), applying hierarchical FDR correction to account for multiple testing.
Results
14-24% of scans were flagged by automated QC tools, but upon visual inspection, only 0-2.4% of outputs were excluded. The pipeline successfully generated 5683 IDPs aligned with UK Biobank and 110 IDPs targeted towards dementia-related changes. We replicated established associations and found novel associations between brain metrics and age, cognition, and dementia-related diagnoses.
Conclusion
The imaging protocol is feasible, acceptable, and yields high-quality data that is usable for both clinical and research purposes. We validated the use of this methodology in a real-world memory clinic population, which demonstrates the potential of this enhanced pipeline to bridge the gap between big data studies and clinical settings.
Key Points
The imaging methods, analysis techniques, and population characteristics in research studies often differ to those in traditional clinical settings.
To bridge this gap, we optimised the UK Biobank imaging framework for memory clinic use by integrating enhanced quality control (QC) and supplementary analyses targeted towards dementia-related changes.
We generated 5683 imaging-derived phenotypes (IDPs) aligned with UK Biobank and 110 supplementary dementia-informed IDPs that captured both established and novel associations between brain metrics and dementia-related clinical phenotypes, highlighting the value of integrating UK Biobank-aligned imaging and analyses in a real-world memory clinic population.
